| (210) | Number of the EPO application | 16715122 |
| (220) | Filing date of the EPO application | 2016.03.17 |
| (80) | EPO patent specification publication (B) | EPB nr. 48/2019, 2019.11.27 |
| (110) | EPO patent number | 3271357 |
| (21) | Number of the application | e 2018 0086 |
| (71) | Name(s) of applicant(s), code of the country | Takeda Pharmaceutical Company Limited, JP; |
| (72) | Name(s) of inventor(s), code of the country | AHMED Saleh, GB;
BARKER Gregory, GB;
CANNING Hannah, GB;
DAVENPORT Richard, GB;
HARRISON David, GB;
JENKINS Kerry, GB;
LIVERMORE David, GB;
WRIGHT Susanne, GB;
KINSELLA Natasha, GB; |
| (73) | Name(s) of owner(s), code of the country | TAKEDA Pharmaceutical Company Limited, JP; |
| (54) | Title of the invention | FUSED BICYCLIC HETEROARYL DERIVATIVES HAVING ACTIVITY AS PHD INHIBITORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 471/04 (2006.01.01); C07D 487/04 (2006.01.01); A61K 31/437 (2006.01.01); A61K 31/519 (2006.01.01); A61P 13/12 (2006.01.01); A61P 9/10 (2006.01.01) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2018.03.31 |
| (30) | Priority | 201504565, 2015.03.18, GB |
| (86) | International application | PCT/JP2016/059782, 2016.03.17 |
| (87) | International publication | WO 2016/148306, 2016.09.22 |